These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11460842)

  • 41. Pharmacokinetic profile of controlled-release carvedilol in patients with left ventricular dysfunction associated with chronic heart failure or after myocardial infarction.
    Packer M; Lukas MA; Tenero DM; Baidoo CA; Greenberg BH;
    Am J Cardiol; 2006 Oct; 98(7A):39L-45L. PubMed ID: 17023231
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study.
    Agostini D; Belin A; Amar MH; Darlas Y; Hamon M; Grollier G; Potier JC; Bouvard G
    J Nucl Med; 2000 May; 41(5):845-51. PubMed ID: 10809201
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Second- and third-generation beta-blocking drugs in chronic heart failure.
    Bristow MR; Abraham WT; Yoshikawa T; White M; Hattler BG; Crisman TS; Lowes BD; Robertson AD; Larrabee P; Gilbert EM
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():291-6. PubMed ID: 9211023
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of carvedilol on plasma levels of interleukin-6 and tumor necrosis factor-alpha in nine patients with dilated cardiomyopathy.
    Matsumura T; Tsushima K; Ohtaki E; Misu K; Tohbaru T; Asano R; Nagayama M; Kitahara K; Umemura J; Sumiyoshi T; Hosoda S
    J Cardiol; 2002 May; 39(5):253-7. PubMed ID: 12048901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intermediate effects of treatment with metoprolol or carvedilol in children with left ventricular systolic dysfunction.
    Williams RV; Tani LY; Shaddy RE
    J Heart Lung Transplant; 2002 Aug; 21(8):906-9. PubMed ID: 12163092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carvedilol reverses elevated pulmonary vascular resistance in a child with dilated cardiomyopathy.
    Horenstein MS; Ross RD; Singh TP; Epstein ML
    Pediatr Cardiol; 2002; 23(1):100-2. PubMed ID: 11922497
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beta-blockers and ventricular arrhythmias in dilated cardiomyopathy.
    Fauchier L; Giraudeau B
    J Am Coll Cardiol; 2000 Jun; 35(7):1993-4. PubMed ID: 10841254
    [No Abstract]   [Full Text] [Related]  

  • 48. Safety and efficacy of carvedilol in very elderly diabetic patients with heart failure.
    Del Sindaco D; Pulignano G; Cioffi G; Tarantini L; Di Lenarda A; De Feo S; Opasich C; Minardi G; Giovannini E; Leggio F
    J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):675-82. PubMed ID: 17700396
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy.
    Toyama T; Hoshizaki H; Seki R; Isobe N; Adachi H; Naito S; Oshima S; Taniguchi K
    J Nucl Med; 2003 Oct; 44(10):1604-11. PubMed ID: 14530474
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myocardial beta-adrenergic receptor density assessed by 11C-CGP12177 PET predicts improvement of cardiac function after carvedilol treatment in patients with idiopathic dilated cardiomyopathy.
    Naya M; Tsukamoto T; Morita K; Katoh C; Nishijima K; Komatsu H; Yamada S; Kuge Y; Tamaki N; Tsutsui H
    J Nucl Med; 2009 Feb; 50(2):220-5. PubMed ID: 19164238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study.
    Bellenger NG; Rajappan K; Rahman SL; Lahiri A; Raval U; Webster J; Murray GD; Coats AJ; Cleland JG; Pennell DJ;
    Heart; 2004 Jul; 90(7):760-4. PubMed ID: 15201244
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial.
    Cice G; Ferrara L; D'Andrea A; D'Isa S; Di Benedetto A; Cittadini A; Russo PE; Golino P; Calabrò R
    J Am Coll Cardiol; 2003 May; 41(9):1438-44. PubMed ID: 12742278
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carvedilol in heart failure.
    Kelly DT
    Cardiology; 1993; 82 Suppl 3():45-9. PubMed ID: 8106165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The effect of carvedilol on coronary flow reserve in patients with dilated cardiomyopathy].
    Fan Y; Lin JH; Dong G; Zhu J; Yin F; Yang SS
    Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):217-9. PubMed ID: 20450653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.
    Lombardo RM; Reina C; Abrignani MG; Rizzo PA; Braschi A; De Castro S
    Am J Cardiovasc Drugs; 2006; 6(4):259-63. PubMed ID: 16913827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure.
    Palazzuoli A; Quatrini I; Vecchiato L; Scali C; De Paola V; Iovine F; Martini G; Nuti R
    Minerva Cardioangiol; 2005 Aug; 53(4):321-8. PubMed ID: 16177676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does beta-blocker treatment influence central sleep apnoea?
    Köhnlein T; Welte T
    Respir Med; 2007 Apr; 101(4):850-3. PubMed ID: 17223328
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of beta-adrenergic receptor antagonism in cardiac sympathetic neuronal remodeling in patients with heart failure.
    Chizzola PR; Gonçalves de Freitas HF; Marinho NV; Mansur JA; Meneghetti JC; Bocchi EA
    Int J Cardiol; 2006 Jan; 106(1):29-34. PubMed ID: 16321662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Left ventricular reverse remodeling with infantile dilated cardiomyopathy and pitfalls of carvedilol therapy.
    Tsuda E; Negishi J; Noritake K; Iwasa T; Abe T
    J Cardiol; 2016 Feb; 67(2):147-52. PubMed ID: 26572957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.